Molina Healthcare has reported adjusted earnings of $4.90 per share for the first quarter of 2022, significantly surpassing the expected $2.82 and up from $4.44 a year prior. The company's total revenues also exceeded forecasts at $7.77 billion, leading to an upward revision of their full-year premium revenue guidance to $29.25 billion, an increase from $28.5 billion. Despite these strong financial results, Molina's stock is currently rated a 'Buy' but is slightly underperforming compared to its industry.